by editor | Apr 28, 2015 | Blog, Bold Stocks, Feature Box, Featured, Medical Stocks, Pharmaceutical, Success
RegeneRx Biopharmaceuticals Inc. (OTCQB: RGRX) is Up 30.77 since our alert at 11:00 AM on April 23rd. Since the alert was issued, volume has been at or near 500K each day. See that alert HERE Proof The Alert Really Went Out: Patent Alert: RegeneRx...
by editor | Apr 23, 2015 | Alert, Blog, Bold Stocks, Bold Stocks Feature, Featured, Medical Stocks
RegeneRx Receives Notice of Allowance For U.S. Patent For Healing and Reversing Heart and Coronary Vessel Damage After A Heart Attack with TB4RegeneRx Biopharmaceuticals Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”) today announced that it...
by editor | May 16, 2011 | Latest Spotlights
DALLAS, TEXAS : StockGuru announces that Regenerx Biopharmaceuticals Inc (OTCBB: RGRX) is in the StockGuru Spotlight. RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tβ4, for tissue and organ protection, repair and...
by editor | Apr 13, 2011 | Latest Spotlights, Penny Stocks Alerts
DALLAS, TEXAS : StockGuru announces that Regenerx Biopharmaceuticals Inc (OTCBB: RGRX) is in the StockGuru Spotlight. RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tβ4, for tissue and organ protection, repair and...
by editor | Mar 16, 2011 | Latest Spotlights, StockGuru Blog
DALLAS, TEXAS : StockGuru announces that Regenerx Biopharmaceuticals Inc (OTCBB: RGRX) is in the StockGuru Spotlight. RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tβ4, for tissue and organ protection, repair and...